植入策略对临时左心室辅助装置过渡至持久机械循环支持的影响
该回顾性多中心研究分析了341例从临时微轴左心室辅助装置(tLVAD)桥接至持久左心室辅助装置(dLVAD)的患者,比较了体外循环、体外生命支持或tLVAD支持下植入dLVAD三种策略。结果显示tLVAD支持下植入组30天生存率显著更优,但1年死亡率无显著差异,且该组术后输血率更低,未增加卒中或泵血栓风险。
要点
- tLVAD支持下植入dLVAD组30天生存率显著优于体外循环组和体外生命支持组。
- 三组1年死亡率无显著差异,术后并发症如RVAD植入、再开胸止血等无显著差异。
- tLVAD支持下植入组术后24小时内输血量显著低于体外循环组和体外生命支持组。
核心结论
- 从tLVAD过渡至dLVAD而不使用额外循环支持未显示术后长期生存差异,但30天生存率更优。
- 仅使用tLVAD支持下植入dLVAD减少了术后输血率,且未增加术后卒中或泵血栓风险。
- 在所选患者中,tLVAD支持下植入dLVAD是安全可行的技术。
研究设计与样本
- 回顾性分析341例患者(19个欧洲中心),于2017年1月至2022年10月期间接受从tLVAD到dLVAD的桥接桥植入。
- 比较了体外循环(组1)、体外生命支持(组2)或tLVAD(组3)支持下植入dLVAD的不同技术结局。
主要发现
- dLVAD植入采用体外循环占70%(n=238,组1),体外生命支持占11%(n=38,组2),tLVAD占19%(n=65,组3)。
- 基线特征中年龄(P=0.140)、体重指数(P=0.388)、肌酐水平(P=0.659)、MELD评分(P=0.190)和透析率(P=0.110)无显著差异。
- 组3术前有创通气和tLVAD植入前心肺复苏的患者显著更少(P=0.009和P<0.001)。
- 组1和组2合并手术比例分别为24%和37%,组3为5%,组1和组2显著高于组3(P<0.001)。
- 逆概率加权后30天死亡率组3显著更优(P=0.012),但1年死亡率无显著差异(P=0.581)。
临床怎么用
- 在所选患者中,tLVAD支持下植入dLVAD可能减少术后输血且不增加卒中或泵血栓风险。
- tLVAD支持下植入dLVAD与更好的30天生存相关,但长期生存无差异。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Bridging from a temporary microaxial left ventricular assist device (tLVAD) to a durable left ventricular assist device (dLVAD) is playing an increasing role in the treatment of terminally ill patients with heart failure. Scant data exist about the best implant strategy. The goal of this study was to analyse differences in the dLVAD implant technique and effects on patient outcomes. METHODS: Data from 341 patients (19 European centres) who underwent a bridge-to-bridge implant from tLVAD to dLVAD between January 2017 and October 2022 were retrospectively analysed. The outcomes of the different implant techniques with the patient on cardiopulmonary bypass, extracorporeal life support or tLVAD were compared. RESULTS: A durable LVAD implant was performed employing cardiopulmonary bypass in 70% of cases (n = 238, group 1), extracorporeal life support in 11% (n = 38, group 2) and tLVAD in 19% (n = 65, group 3). Baseline characteristics showed no significant differences in age (P = 0.140), body mass index (P = 0.388), creatinine level (P = 0.659), the Model for End-Stage Liver Disease (MELD) score (P = 0.190) and rate of dialysis (P = 0.110). Group 3 had significantly fewer patients with preoperatively invasive ventilation and cardiopulmonary resuscitation before the tLVAD was implanted (P = 0.009 and P < 0.001 respectively). Concomitant procedures were performed more often in groups 1 and 2 compared to group 3 (24%, 37% and 5%, respectively, P < 0.001). The 30-day mortality data showed significantly better survival after an inverse probability of treatment weighting in group 3, but the 1-year mortality showed no significant differences among the groups (P = 0.012 and 0.581, respectively). Postoperative complications like the rate of right ventricular assist device (RVAD) implants or re-thoracotomy due to bleeding, postoperative respiratory failure and renal replacement therapy showed no significant differences among the groups. Freedom from the first adverse event like stroke, driveline infection or pump thrombosis during follow-up was not significantly different among the groups. Postoperative blood transfusions within 24 h were significantly higher in groups 1 and 2 compared to surgery on tLVAD support (P < 0.001 and P = 0.003, respectively). CONCLUSIONS: In our analysis, the transition from tLVAD to dLVAD without further circulatory support did not show a difference in postoperative long-term survival, but a better 30-day survival was reported. The implant using only tLVAD showed a reduction in postoperative transfusion rates, without increasing the risk of postoperative stroke or pump thrombosis. In this small cohort study, our data support the hypothesis that a dLVAD implant on a tLVAD is a safe and feasible technique in selected patients.
引用
- Meyer AL, Lewin D, Billion M, et al. Influence of implant strategy on the transition from temporary left ventricular assist device to durable mechanical circulatory support. Eur J Cardiothorac Surg. 2024. PMID: 39259187. doi:10.1093/ejcts/ezae333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。